Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Regulation of morphogen signaling pathways by recurrent hypermotif circuits.

Created on 06 Oct 2026

Authors

Miri Adler, Ruslan Medzhitov

Published in

Proceedings of the National Academy of Sciences of the United States of America. Volume 123. Issue 41. Pages e2538060123. Oct 13, 2026. Epub Oct 05, 2026.

Abstract

Morphogen signaling pathways orchestrate cell fate and tissue patterning during embryo development through intricate intercellular communication. While much is known about the molecular components of these pathways, the underlying regulatory logic shaping their integration remains unclear. Here, we develop a computational framework to uncover higher-order network structures, hypermotifs, that link gene regulatory circuits within and between cells via morphogen signaling. Applying this framework to single-cell RNA sequencing data from human intestinal development, we identify recurrent hypermotif topologies that mediate communication between epithelial and fibroblast populations. These cell-cell hypermotif circuits involve feedback and feedforward loops embedded within signaling pathways. Dynamical modeling reveals that such circuits can generate emergent behaviors, including oscillatory and antagonistic responses. Our results highlight hypermotifs as key design principles in developmental regulatory networks, providing a systems-level understanding of morphogen signal integration across cell types.

PMID:
42832668
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement